$CLS

Chawla Mandeep sold $6.8M of CLS

Chawla Mandeep (Chief Financial Officer) sold 17,000 shares of CELESTICA INC (CLS) at an average of $399.65 ($394.25–$412.99, $6.79M total) across 15 trades on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Chawla Mandeep
Published Jun 18, 2026, 12:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CLS
Neutral
medium confidence
Mentioned
$CLS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLSNeutralLow
01

Why it matters

The disclosure provides a concrete insider activity datapoint (~$6.79M) but does not include new financial results, guidance, or business developments.

02

Market read

A CFO’s 10b5-1 sale of ~$6.79M in CLS is more sentiment/positioning information than a fundamental catalyst.

03

What to watch

Traders may over-weight the sale size; the key nuance is that the plan was pre-arranged, and the filing date is after the trades were already executed (2026-06-15).

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-17 for sales executed 2026-06-15

Background

SEC Form 4 reports an officer (CFO) open-market sale of Celestica shares, executed across 15 trades on 2026-06-15.

Company-level read

Ticker impact

$CLSNeutralMedium confidence
Context

Celestica CFO Chawla Mandeep sold about 17,000 CLS shares in an open-market sale under a 10b5-1 plan, totaling ~$6.79M.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is a primary Form 4 disclosure with sizable dollar value, but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretive power.

Market effects

Minimal sector read-through; this is company-specific insider transaction data without operational or guidance content.

No clear regional spillover indicated by the filing details.

Limited global relevance; no deal, regulation, or macro linkage is described.

Counterpoint

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect liquidity/compensation mechanics rather than bearish fundamentals.

Key entities

  • Celestica Inc

    Issuer of CLS shares; CFO insider sale disclosed on Form 4.

  • Chawla Mandeep

    Chief Financial Officer who sold ~17,000 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CLSMed

Canada Trade War: What It Means for Electronics Manufacturing · EMSNow

Canada and the US imposed tariffs on each other's exports, including electronics, with no expiry date. Canadian electronics exports are heavily dependent on the US, making the sector vulnerable. Celestica and other EMS providers may relocate production to mitigate costs. Provincial and federal governments are offering support programs. Investors should watch Q3 earnings for affected companies and the impact of Canada's retaliatory tariffs on September 8.

$CLSMedAI 8/10

Celestica Stock Falls 2.63%: Why TSX:CLS Is in Focus After AI Infrastructure Boom, $20.5 Billion Revenue Outlook and New 2027 Growth Catalysts

Celestica Inc. (TSX:CLS) shares fell 2.63% on Aug. 14, 2026 despite strong Q2 results and raised outlook. Q2 revenue rose about 62% to US$4.70B and adjusted EPS to US$2.54. 2026 revenue guidance was lifted to about US$20.5B, adjusted EPS to US$11.30, and FCF to US$600M, with 2027 growth expected to accelerate on AI infrastructure demand.